10th Edition of World Congress on Infectious Diseases & One Health

Event type: Medical conference, infectious diseases congress, public health, epidemiology, microbiology, diagnostics, vaccines, antimicrobial resistance, global health, and One Health collaboration event.

Positioning summary: This is a high-value scientific and healthcare-focused congress where the strongest commercial relevance usually comes from pharmaceutical companies, vaccine developers, diagnostics firms, laboratory solution providers, hospital systems, clinical research organizations, public health institutions, academic medical centers, and health technology companies working across human, animal, and environmental health. Because the event is built around the One Health framework, it attracts stakeholders interested in the intersection of infectious disease surveillance, prevention, treatment, outbreak response, zoonotic diseases, antimicrobial stewardship, and cross-sector collaboration.

1️⃣ Who attends: buyers / attendees

The attendee profile for this congress is not limited to one narrow buyer category. It typically brings together a mixed audience of clinical, scientific, academic, institutional, and commercial participants. For outreach and business-fit purposes, the best buyer-side audience is usually found among decision-makers involved in infectious disease strategy, diagnostics adoption, therapeutic development, laboratory expansion, epidemiology programs, hospital infection control, public health partnerships, and research collaborations.

Main attendee groups usually include:

• Infectious disease physicians and consultants
• Clinical microbiologists and laboratory directors
• Hospital infection prevention and infection control leaders
• Epidemiologists and surveillance specialists
• Public health officials and health agency representatives
• Pharmaceutical and vaccine company medical and scientific teams
• Diagnostics and molecular testing companies
• Clinical research organizations and trial operations teams
• Academic researchers, professors, and principal investigators
• Biotechnology companies focused on anti-infectives, vaccines, and immunology
• Veterinary health and zoonotic disease experts under the One Health theme
• Environmental health and food safety professionals
• NGOs, multilateral health bodies, and policy-focused public health organizations
• Medical device and laboratory equipment suppliers
• Health data, surveillance, AI, and digital health solution providers

Best buyer personas within the attendee mix:

• Director of Infectious Diseases
• Head of Clinical Microbiology
• Medical Director
• Director of Infection Prevention
• Laboratory Director
• Director of Epidemiology
• Vice President, Medical Affairs
• Director, Scientific Affairs
• Clinical Development Director
• Translational Medicine Lead
• Public Health Program Director
• Research Partnerships Director
• Business Development Director, Diagnostics
• Regional Commercial Director, Life Sciences
• Global Product Manager, Infectious Diseases

In short, this congress usually attracts a scientifically strong audience, but the true commercial value sits with the institutions and companies funding research, deploying diagnostics, running infection-control programs, expanding lab capabilities, commercializing therapeutics, or supporting public-health delivery.

2️⃣ Where the show is happening + attendee geographic origin

We recommend confirming the final venue city and dates from the organizer’s official page before campaign launch, because medical congress editions can shift by year, host city, or hybrid format.

Location pattern: Events under this type of world congress branding are commonly hosted in major international conference destinations with strong medical, academic, and travel infrastructure. Depending on the edition, attendance often includes both in-person and internationally sourced delegates.

Attendee geographic origin usually includes:

• Host-country delegates from local hospitals, universities, and public health bodies
• Regional attendees from neighboring countries
• International researchers and speakers from North America, Europe, Asia-Pacific, the Middle East, and Africa
• Global life sciences companies with infectious disease, vaccine, microbiology, or diagnostics portfolios
• Cross-border health organizations involved in surveillance, preparedness, and global health policy

Best geographic targeting approach:

• Primary: host country and regional healthcare ecosystem
• Secondary: global pharmaceutical, biotechnology, diagnostics, and research institutions
• Tertiary: international NGOs, universities, and public health agencies focused on outbreak preparedness and One Health programs

3️⃣ Audience reach: local / national / global

Audience reach: Global, with regional concentration around the host country.

This is not a purely local trade fair. The “World Congress” positioning and the subject matter of infectious diseases naturally give it international relevance. Topics like outbreak management, emerging pathogens, vaccine science, antimicrobial resistance, zoonoses, and surveillance networks are global by nature, so the audience normally extends beyond one country.

That said, the practical audience mix often follows a three-layer pattern:

• Local layer: nearby hospitals, universities, labs, and healthcare providers
• National layer: medical associations, disease institutes, government health bodies, and domestic life sciences companies
• Global layer: multinational pharma, biotech, diagnostics, academic researchers, speakers, and international collaborators

For campaign planning, we should classify this event as international in brand, global in relevance, and regionally anchored in physical attendance.

4️⃣ Sample buyer company names + websites

Below is a practical sample account list of organizations that are highly aligned with infectious diseases, diagnostics, vaccines, microbiology, hospital infection control, public health, and One Health themes. These are strong fit examples for targeting based on this event’s attendee logic.

Top accounts we would prioritize first: Pfizer, GSK, Roche, Abbott, Thermo Fisher Scientific, bioMérieux, QIAGEN, Cepheid, BD, and major hospital systems with infectious disease and microbiology leadership.

5️⃣ Job profiles, industries & event type

Best job profiles to target:

• Chief Medical Officer
• Medical Director
• Director of Infectious Diseases
• Head of Clinical Microbiology
• Director of Infection Prevention
• Director of Epidemiology
• Scientific Affairs Director
• Medical Affairs Director
• Clinical Development Director
• Translational Research Lead
• Public Health Program Director
• Laboratory Director
• Head of Diagnostics
• Global Product Manager, Infectious Disease Portfolio
• Business Development Director
• Research Collaborations Manager
• Hospital Procurement or Strategic Sourcing lead for lab/diagnostics categories

Best industry filters to use from the industry list:

• Hospital & Health Care
• Biotechnology
• Pharmaceuticals
• Medical Devices
• Research
• Higher Education
• Health, Wellness & Fitness
• Nonprofit Organization Management
• Government Administration
• International Affairs
• Information Technology & Services
• Computer Software
• Environmental Services
• Veterinary

Most relevant industry combinations by event theme:

• Core medical and science: Hospital & Health Care, Biotechnology, Pharmaceuticals, Medical Devices, Research
• Academic and policy ecosystem: Higher Education, Government Administration, International Affairs, Nonprofit Organization Management
• One Health extension: Veterinary, Environmental Services, Research
• Data and surveillance layer: Information Technology & Services, Computer Software

Event type classification: International medical and scientific congress with B2B relevance across healthcare, life sciences, diagnostics, and public health.

6️⃣ Estimated attendance / expected total footfall

For this specific congress edition, the exact expected footfall should be validated from the organizer’s official materials, because medical conferences in this category can vary significantly depending on location, partnership structure, speaker lineup, and hybrid participation.

Practical estimate: this type of specialized infectious diseases congress often attracts a mid-scale expert audience rather than a mass-expo crowd. A reasonable planning range is usually 300 to 1,000+ attendees, with the strongest value concentrated in speaker quality, institutional profile, and scientific relevance rather than sheer volume.

How we should interpret attendance quality:

• This is typically not a giant general medical exhibition with tens of thousands of visitors.
• It is more likely a focused, high-intent audience made up of clinicians, researchers, scientists, and healthcare decision-makers.
• Commercial value is usually determined by title seniority and institutional quality, not only total footfall.

If your team needs a more exact qualification, we can refine the attendance expectation once we review the official event page, past editions, scientific committee, sponsor level, and venue size.

7️⃣ Key focus areas & buyer engagement

Key focus areas likely covered at this event:

• Emerging and re-emerging infectious diseases
• One Health and zoonotic disease management
• Antimicrobial resistance
• Vaccines and immunization strategy
• Clinical microbiology and laboratory innovation
• Molecular diagnostics and rapid testing
• Outbreak surveillance and epidemiology
• Global health preparedness and pandemic response
• Hospital infection prevention and control
• Therapeutics, anti-infectives, and translational research
• Environmental and animal health interfaces
• Data-driven public health, surveillance platforms, and AI-enabled disease monitoring

Best buyer engagement angles:

• Scientific partnership and collaboration opportunities
• Clinical research and investigator engagement
• Laboratory modernization and testing workflow improvement
• Hospital infection prevention solution alignment
• Diagnostic product awareness among microbiology and infectious disease specialists
• Vaccine and therapeutic stakeholder engagement
• Public health and surveillance technology positioning
• Cross-sector One Health collaboration with veterinary and environmental experts

Most monetizable buyer segments from a business perspective:

• Diagnostics companies
• Pharmaceutical and vaccine manufacturers
• Clinical laboratory solution providers
• Hospital systems and academic medical centers
• Biotechnology firms focused on infectious disease pipelines
• Clinical research organizations
• Public health institutions and disease surveillance programs
• Health software and epidemiology intelligence companies

8️⃣ Client-product fit note

To sharpen the final buyer recommendations properly, we need your client’s website.

Please share the client website and we will review the product, positioning, use cases, and target market, then tell you which buyer segments from this event are the best fit.

Why this matters: the right target audience changes significantly depending on what the client actually sells.

Examples:

• If the client sells diagnostics, testing platforms, PCR, sequencing, or laboratory reagents: we should prioritize lab directors, clinical microbiologists, infectious disease specialists, pathology networks, hospital labs, and diagnostics companies.
• If the client sells pharmaceutical, vaccine, or therapeutic solutions: we should prioritize medical affairs leaders, clinical development teams, infectious disease physicians, trial leaders, and scientific affairs decision-makers.
• If the client sells healthcare software, disease surveillance tools, AI analytics, or public health data systems: we should prioritize epidemiology heads, public health program leaders, hospital digital strategy teams, and health informatics decision-makers.
• If the client sells hospital infection prevention products: we should prioritize infection control directors, hospital quality leaders, microbiology labs, and clinical operations stakeholders.
• If the client sells veterinary, zoonotic, or environmental health solutions: we should prioritize One Health researchers, veterinary institutions, environmental services organizations, and public-sector disease monitoring bodies.

Once we review the client site, we can refine:

• best industries to prioritize
• best job titles to target
• best company types to include or exclude
• whether the event is stronger for scientific outreach, healthcare commercial outreach, partnership outreach, or institutional engagement

9️⃣ Final recommendation

Overall assessment: this is a strong specialist event for healthcare and life-sciences targeting, especially if your client is aligned with infectious disease, microbiology, diagnostics, vaccines, public health, hospital infection prevention, or One Health-related research and technology.

Best-fit sectors:

• Pharmaceuticals
• Biotechnology
• Medical Devices
• Hospital & Health Care
• Research
• Higher Education
• Government Administration
• Nonprofit Organization Management
• Veterinary
• Environmental Services
• Information Technology & Services
• Computer Software

Best-fit account categories:

• Global vaccine and pharmaceutical companies
• Molecular diagnostics and microbiology companies
• Hospital systems and academic medical centers
• Reference laboratories and pathology networks
• Biotech innovators in anti-infectives and immunology
• Clinical research and public health organizations
• Digital surveillance and health intelligence providers

Quality rating for B2B relevance: 8.5/10

Why the rating is strong:

• The topic area is highly specialized and commercially important.
• The event likely attracts scientifically credible and professionally relevant attendees.
• Buyer quality can be very strong in diagnostics, vaccines, hospital systems, and public-health programs.
• The One Health theme broadens the audience beyond traditional medicine into veterinary and environmental domains.

Main caution:

• This is likely a more focused congress than a huge expo, so volume may be lower than broad healthcare trade shows.
• The strongest value comes from title quality, institutional prestige, and subject alignment rather than raw attendee count.

Recommended next step: please send us the client website, and we will review it and tell you the best buyer categories, company types, industries, and job titles to prioritize specifically for the 10th Edition of World Congress on Infectious Diseases & One Health.